Literature DB >> 32267322

High Serum Netrin-1 and IL-1β in Elderly Females with ACS: Worse Prognosis in 2-years Follow-up.

Paola Leocádio1, Penélope Menta1, Melissa Dias1, Júlia Fraga1, Alessandra Goulart2, Itamar Santos2, Paulo Lotufo2,3, Isabela Bensenor2,3, Jacqueline Alvarez-Leite1.   

Abstract

BACKGROUND: Several markers have been evaluated for a potential impact on clinical decisions or mortality prediction in acute coronary syndrome (ACS), including Netrin-1 and IL-1β that have been associated with cardiovascular disease.
OBJECTIVE: Our study examined the prognostic value of Netrin-1 and IL-1β in patients with ACS (2-year follow-up).
METHODS: We evaluate Netrin-1, IL-1β and other risk factors in the serum sample of 803 patients. Kaplan-Meier curves and Cox regression were used for the analysis of all-cause mortality, cardiovascular mortality, and a combined outcome of fatal myocardial infarction (MI) or new non-fatal MI, considering p-value < 0.05.
RESULTS: There were 115 deaths from all causes, 78 deaths due to cardiovascular causes and 67 events in combined outcomes. Netrin-1 levels above the median (>44.8 pg/mL) were associated with a worse prognosis (all-cause mortality and cardiovascular mortality) in elderly females, even after model adjustment (HR: 2.08, p = 0.038 and HR: 2.68, p = 0.036). IL-1β levels above the median (>13.4 pg/mL) in elderly females were associated with increased risk of all outcomes after adjustment (all-cause mortality - HR: 2.03, p = 0.031; cardiovascular mortality - HR: 3.01, p = 0.013; fatal MI or new non-fatal MI - HR: 3.05, p = 0.029). For males, no associations were observed between Netrin-1 or IL-1β and outcomes.
CONCLUSION: High serum levels of Netrin-1 and IL-1β showed significant association with worse prognosis in elderly females. They may be useful as prognostic indicators in ACS. (Arq Bras Cardiol. 2020; 114(3):507-514).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32267322      PMCID: PMC7792717          DOI: 10.36660/abc.20190035

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  36 in total

Review 1.  Healing after myocardial infarction.

Authors:  Georg Ertl; Stefan Frantz
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Inflammation and its resolution as determinants of acute coronary syndromes.

Authors:  Peter Libby; Ira Tabas; Gabrielle Fredman; Edward A Fisher
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

4.  Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery.

Authors:  Ganesan Ramesh; Catherine D Krawczeski; Jessica G Woo; Yu Wang; Prasad Devarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 8.237

5.  Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism.

Authors:  Jun Zhang; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2010-01-12       Impact factor: 5.000

6.  Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury.

Authors:  W Brian Reeves; Osun Kwon; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-30

7.  Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

8.  Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study.

Authors:  Tanica Lyngdoh; Pedro Marques-Vidal; Fred Paccaud; Martin Preisig; Gérard Waeber; Murielle Bochud; Peter Vollenweider
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

9.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.

Authors:  Janine M van Gils; Merran C Derby; Luciana R Fernandes; Bhama Ramkhelawon; Tathagat D Ray; Katey J Rayner; Sajesh Parathath; Emilie Distel; Jessica L Feig; Jacqueline I Alvarez-Leite; Alistair J Rayner; Thomas O McDonald; Kevin D O'Brien; Lynda M Stuart; Edward A Fisher; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

10.  Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study).

Authors:  Alessandra C Goulart; Itamar S Santos; Debora Sitnik; Henrique L Staniak; Ligia M Fedeli; Carlos Alberto Pastore; Nelson Samesima; Marcio S Bittencourt; Alexandre C Pereira; Paulo A Lotufo; Isabela M Bensenor
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more
  3 in total

Review 1.  Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.

Authors:  Laura Ziegon; Martin Schlegel
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

2.  Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression.

Authors:  Martin Schlegel; Monika Sharma; Emily J Brown; Alexandra A C Newman; Yannick Cyr; Milessa Silva Afonso; Emma M Corr; Graeme J Koelwyn; Coen van Solingen; Jonathan Guzman; Rubab Farhat; Cyrus A Nikain; Lianne C Shanley; Daniel Peled; Ann Marie Schmidt; Edward A Fisher; Kathryn J Moore
Journal:  Circ Res       Date:  2021-07-22       Impact factor: 23.213

3.  Acute Coronary Syndrome in Elderly Women: Inflammation Strikes Again.

Authors:  Bruno Rocha; Carlos Aguiar
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.